A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin
Clinical trial NCT06081166 · COMPLETED
Trial details
- NCT number
- NCT06081166
- Sponsor
- NewAmsterdam Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-11
- Primary completion
- 2023-12-02
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.